Figure 7.

Change in quality of life over time in a randomized controlled trial of Tesomet for weight loss in with hypothalamic obesity. Data are mean change from baseline in physical (A) and mental (B) component scores of SF36 v2 for each treatment group at each scheduled visit (weeks from baseline). Last observation carried forward imputation was used for missing data. Error bars are s.e.m. *P  < 0.05 in a baseline adjusted ANCOVA model with treatment as factor and baseline value as covariate.